Aldeyra director awarded new stock options
Aldeyra Therapeutics director Douglas Richard received new stock option awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Aldeyra Therapeutics director Douglas Richard received new stock option awards. The Form 4 shows three option grants to buy Common Stock at an exercise price of $1.72 per share, covering 2,323, 19,909, and 70,000 underlying shares, respectively.
Each grant becomes exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided he continues serving in the specified roles: as a member of the Board, as Chairperson of the Board, and as a member of the Nominating/Corporate Governance Committee.
Insider Trade Summary
Grant/Award: 92,232 shares
Grant/Award
3 txns
Insider
DOUGLAS RICHARD
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 70,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 19,909 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 2,323 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 92,232 contracts (Direct)
Footnotes (3)
- F1. Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
- F2. Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date.
- F3. Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.
Key Figures
Option grant 1 size: 2,323 shares
Option grant 2 size: 19,909 shares
Option grant 3 size: 70,000 shares
+2 more
5 metrics
Option grant 1 size
2,323 shares
Underlying Common Stock for first stock option grant
Option grant 2 size
19,909 shares
Underlying Common Stock for second stock option grant
Option grant 3 size
70,000 shares
Underlying Common Stock for third stock option grant
Exercise price
<money>$1.72</money> per share
Exercise price for all three stock option grants
Expiration date
<date>June 8, 2036</date>
Expiration for each stock option grant
Key Terms
Stock Option (Right to Buy), Grant, award, or other acquisition, Nominating/Corporate Governance Committee, exercise price
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Nominating/Corporate Governance Committee financial
"member of the Nominating/Corporate Governance Committee of the Board of Directors"
A nominating/corporate governance committee is a small group of a company’s board members tasked with choosing and evaluating directors and setting the rules that guide how the board operates. Think of it as the board’s hiring and rule-making team: it shapes leadership, board makeup, independence and ethical standards, which in turn influence how well the company is overseen and how investor interests are protected.
exercise price financial
"conversion_or_exercise_price: 1.7200"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Aldeyra Therapeutics (ALDX) report for Douglas Richard?
Aldeyra Therapeutics reported that director Douglas Richard received three stock option grants. These options give him the right to buy Common Stock at a fixed price, functioning as equity-based compensation tied to his board and committee service roles.
How many Aldeyra Therapeutics stock options were granted to Douglas Richard?
Douglas Richard was granted options over 2,323, 19,909, and 70,000 underlying shares. Each grant is a separate award linked to different board responsibilities, providing potential future ownership if exercised after vesting conditions are satisfied.
What is the exercise price of Douglas Richard’s Aldeyra Therapeutics stock options?
All three stock option grants carry an exercise price of $1.72 per share. This is the price at which he can buy Aldeyra Therapeutics Common Stock once the options vest and are exercisable, subject to his continued service conditions.
When do Douglas Richard’s Aldeyra Therapeutics stock options become exercisable?
Each option grant becomes exercisable with respect to 100% of the shares on the one-year anniversary of the grant date. Exercisability requires Douglas Richard to maintain continuous service in the specified board, chairperson, or committee roles through that vesting date.
What roles are tied to Douglas Richard’s Aldeyra Therapeutics stock option vesting?
The vesting terms are tied to his service as a Board member, as Chairperson of the Board, and as a member of the Nominating/Corporate Governance Committee. Each grant’s exercisability depends on him remaining in the related role through the one-year vesting anniversary.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates